OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Pathophysiology of Uric Acid Homeostasis
Christopher Estiverne, Asim K. Mandal, David B. Mount
Seminars in Nephrology (2020) Vol. 40, Iss. 6, pp. 535-549
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
Robert Eckenstaler, Ralf A. Benndorf
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6678-6678
Open Access | Times Cited: 77

Exploring the mechanism underlying hyperuricemia using comprehensive research on multi-omics
Hengrui Liu, Ruolin Xie, Qiongqiong Dai, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 27

Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions
Qingqing Han, Qi-dong Ren, Xu Guo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 11

Ganoderma lucidumpolysaccharide peptide alleviates hyperuricemia by regulating adenosine deaminase and urate transporters
Simei Lin, Jia Meng, Fei Li, et al.
Food & Function (2022) Vol. 13, Iss. 24, pp. 12619-12631
Closed Access | Times Cited: 35

Mechanisms of theaflavins against gout and strategies for improving the bioavailability
Jingzi Chen, Yanchao Zheng, Sihan Gong, et al.
Phytomedicine (2023) Vol. 114, pp. 154782-154782
Closed Access | Times Cited: 19

Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice
Yueyi Zhang, Shan Wang, Xuan Dai, et al.
Journal of Ethnopharmacology (2023) Vol. 312, pp. 116530-116530
Closed Access | Times Cited: 18

Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions
Shuangling Yang, Haimei Liu, Xian-Ming Fang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111932-111932
Open Access | Times Cited: 6

Urate Transporters in the Kidney: What Clinicians Need to Know
Sungjin Chung, Gheun‐Ho Kim
Electrolytes & Blood Pressure (2021) Vol. 19, Iss. 1, pp. 1-1
Open Access | Times Cited: 33

Identification of Hyperuricemia Alleviating Peptides from Yellow Tuna Thunnus albacares
Hao Li, Yulian Ding, Yan Fan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 21, pp. 12083-12099
Closed Access | Times Cited: 5

Relationship between serum uric acid levels and osteoporosis
Rong Xu, Difei Lian, Yan Xie, et al.
Endocrine Connections (2023) Vol. 12, Iss. 11
Open Access | Times Cited: 12

Anti-hyperuricemia bioactive peptides: a review on obtaining, activity, and mechanism of action
Ying Chen, Hongyan Li, Yunfei Cai, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 5714-5736
Closed Access | Times Cited: 4

Eurycomanol alleviates hyperuricemia by promoting uric acid excretion and reducing purine synthesis
Ruixia Bao, Qian Chen, Zheng Li, et al.
Phytomedicine (2021) Vol. 96, pp. 153850-153850
Closed Access | Times Cited: 25

Early life PCB138 exposure induces kidney injury secondary to hyperuricemia in male mice
Fengkai Ruan, Changqian Liu, Weiping Hu, et al.
Environmental Pollution (2022) Vol. 301, pp. 118977-118977
Closed Access | Times Cited: 17

Purine metabolites and complex diseases: role of genes and nutrients
Kendra L Nelson, V. Saroja Voruganti
Current Opinion in Clinical Nutrition & Metabolic Care (2021) Vol. 24, Iss. 4, pp. 296-302
Closed Access | Times Cited: 22

Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury
Sheng Wang, Liyun Zhang, Dongsheng Hao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15

Alleviation of Hyperuricemia by Strictinin in AML12 Mouse Hepatocytes Treated with Xanthine and in Mice Treated with Potassium Oxonate
Kuo‐Ching Huang, Yu‐Ting Chang, Rosita Pranata, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 329-329
Open Access | Times Cited: 8

Requiem for Urate Lowering in CKD?
David B. Mount
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 5, pp. 525-527
Closed Access | Times Cited: 2

Association of urinary excretion rates of uric acid with biomarkers of kidney injury in patients with advanced chronic kidney disease
Antía López Iglesias, Marta Blanco Pardo, Catuxa Rodríguez Magariños, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304105-e0304105
Open Access | Times Cited: 2

A New Perspective on the Prediction and Treatment of Stroke: The Role of Uric Acid
Bingrui Zhu, Xiaobin Huang, Jiahao Zhang, et al.
Neuroscience Bulletin (2024)
Closed Access | Times Cited: 2

Research progress in arthritis treatment with the active components of Herba siegesbeckiae
Xiaoqian Lv, Xiaoyu Wang, Xuelei Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115939-115939
Open Access | Times Cited: 6

Food-derived peptides as novel therapeutic strategies for NLRP3 inflammasome-related diseases: a systematic review
Ziqi Zhang, Yuan Zhang, Meiying Zhang, et al.
Critical Reviews in Food Science and Nutrition (2023), pp. 1-32
Closed Access | Times Cited: 6

The associations between fasting glucose, lipids and uric acid levels strengthen with the decile of uric acid increase and differ by sex
Xiao Wang, Shan Zhong, Xiao Guo
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 12, pp. 2786-2793
Closed Access | Times Cited: 10

TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia
Meishan Yan, Minghui Xu, Zhanni Li, et al.
Blood Cells Molecules and Diseases (2022) Vol. 96, pp. 102666-102666
Closed Access | Times Cited: 9

Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M)
Ana Perdomo-Ramírez, Elizabeth Córdoba-Lanús, Carmen Jane Trujillo-Frías, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8455-8455
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top